SCHEMBL174383

SCHEMBL174383

CC(C)(C)c1cc2nc(C(F)(F)c3ccc(F)cc3)nc(Nc3cc[nH]n3)c2s1

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PRKCI P41743 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL175189 0.85 NTRK1 (0.32)
SCHEMBL166022 0.85 NTRK1 (0.43)
SCHEMBL175046 0.81 PAK4 (0.33) PRKCI
SCHEMBL174490 0.79 AURKB (0.41)
SCHEMBL174933 0.79 AURKA (0.40) PRKCI
SCHEMBL173922 0.79 JAK2 (0.47) PRKCI
SCHEMBL174171 0.78 NTRK1 (0.41)
SCHEMBL174445 0.77 CCNE2 (0.44)
SCHEMBL174795 0.77 FLT3 (0.36)
SCHEMBL173271 0.76 AURKB (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611812-A1 THIENOPYRIDINE AND THIENOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2013-07-10 EP disclosed
WO-2012030894-A1 THIENOPYRIDINE AND THIENOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2012-03-08 WO disclosed
WO-2012030894-A1 THIENOPYRIDINE AND THIENOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2012-03-08 WO disclosed